Eli Lilly’s stock price fell to $872.91. Shareholders have lost 8.3% of their capital, which is disappointing considering the ...

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

Shanghai-based brain-computer interface (BCI) company StairMed, which claims to outperform Elon Musk’s Neuralink in certain ...

and Lilly Asia Ventures, a spin-off of American pharmaceutical giant Eli Lilly. StairMed called it the largest fundraising round for a Chinese implantable BCI company, according to a post on ...

By capitalizing on its advantages for business of all sizes, Wisconsin is seeing significant growth in legacy and emerging ...

As the demand for GLP-1 weight loss medications such as Ozempic, Wegovy, and Zepbound continues to skyrocket, new survey results from 9amHealth reveal that access to these medications has become a ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Foreign investments in Flanders created 5,000 new jobs in 2024, with the United States accounting for 21.6% of total projects, including a strong presence in the pharmaceutical and biotech sectors.

Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 million (US$570 million) investment in Canada, creating more than 700 ...

Two months after launching Pep2Tango Therapeutics, VC firm Versant Ventures is unveiling another ... the hottest tickets in the obesity space. Eli Lilly’s weight loss blockbuster Zepbound ...